JP2016521752A5 - - Google Patents

Download PDF

Info

Publication number
JP2016521752A5
JP2016521752A5 JP2016519661A JP2016519661A JP2016521752A5 JP 2016521752 A5 JP2016521752 A5 JP 2016521752A5 JP 2016519661 A JP2016519661 A JP 2016519661A JP 2016519661 A JP2016519661 A JP 2016519661A JP 2016521752 A5 JP2016521752 A5 JP 2016521752A5
Authority
JP
Japan
Prior art keywords
antibody
composition according
burkholderia
composition
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016519661A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016521752A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/042201 external-priority patent/WO2014201305A1/en
Publication of JP2016521752A publication Critical patent/JP2016521752A/ja
Publication of JP2016521752A5 publication Critical patent/JP2016521752A5/ja
Pending legal-status Critical Current

Links

JP2016519661A 2013-06-13 2014-06-12 Burkholderia感染の処置のための組成物および方法 Pending JP2016521752A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361834846P 2013-06-13 2013-06-13
US61/834,846 2013-06-13
PCT/US2014/042201 WO2014201305A1 (en) 2013-06-13 2014-06-12 Compositions and methods for the treatment of burkholderia infections

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2017109356A Division JP2017143841A (ja) 2013-06-13 2017-06-01 Burkholderia感染の処置のための組成物および方法
JP2018187557A Division JP6832901B2 (ja) 2013-06-13 2018-10-02 Burkholderia感染の処置のための組成物および方法

Publications (2)

Publication Number Publication Date
JP2016521752A JP2016521752A (ja) 2016-07-25
JP2016521752A5 true JP2016521752A5 (https=) 2017-07-13

Family

ID=51177157

Family Applications (8)

Application Number Title Priority Date Filing Date
JP2016519661A Pending JP2016521752A (ja) 2013-06-13 2014-06-12 Burkholderia感染の処置のための組成物および方法
JP2017109356A Ceased JP2017143841A (ja) 2013-06-13 2017-06-01 Burkholderia感染の処置のための組成物および方法
JP2018187557A Active JP6832901B2 (ja) 2013-06-13 2018-10-02 Burkholderia感染の処置のための組成物および方法
JP2019223668A Withdrawn JP2020037595A (ja) 2013-06-13 2019-12-11 Burkholderia感染の処置のための組成物および方法
JP2022088322A Pending JP2022116236A (ja) 2013-06-13 2022-05-31 Burkholderia感染の処置のための組成物および方法
JP2023041844A Ceased JP2023072074A (ja) 2013-06-13 2023-03-16 Burkholderia感染の処置のための組成物および方法
JP2024034820A Ceased JP2024060001A (ja) 2013-06-13 2024-03-07 Burkholderia感染の処置のための組成物および方法
JP2025078757A Pending JP2025122007A (ja) 2013-06-13 2025-05-09 Burkholderia感染の処置のための組成物および方法

Family Applications After (7)

Application Number Title Priority Date Filing Date
JP2017109356A Ceased JP2017143841A (ja) 2013-06-13 2017-06-01 Burkholderia感染の処置のための組成物および方法
JP2018187557A Active JP6832901B2 (ja) 2013-06-13 2018-10-02 Burkholderia感染の処置のための組成物および方法
JP2019223668A Withdrawn JP2020037595A (ja) 2013-06-13 2019-12-11 Burkholderia感染の処置のための組成物および方法
JP2022088322A Pending JP2022116236A (ja) 2013-06-13 2022-05-31 Burkholderia感染の処置のための組成物および方法
JP2023041844A Ceased JP2023072074A (ja) 2013-06-13 2023-03-16 Burkholderia感染の処置のための組成物および方法
JP2024034820A Ceased JP2024060001A (ja) 2013-06-13 2024-03-07 Burkholderia感染の処置のための組成物および方法
JP2025078757A Pending JP2025122007A (ja) 2013-06-13 2025-05-09 Burkholderia感染の処置のための組成物および方法

Country Status (7)

Country Link
US (1) US20160175440A1 (https=)
EP (1) EP3008088B1 (https=)
JP (8) JP2016521752A (https=)
AU (4) AU2014278037A1 (https=)
CA (1) CA2915210A1 (https=)
ES (1) ES2746971T3 (https=)
WO (1) WO2014201305A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012010793A (es) 2010-03-29 2013-05-09 Univ Southern California Composiciones y metodos para la eliminacion de biopeliculas.
EP2613797B1 (en) 2010-09-09 2015-11-04 University Of Southern California Compositions and methods for the removal of biofilms
US11274144B2 (en) 2013-06-13 2022-03-15 Research Institute At Nationwide Children's Hospital Compositions and methods for the removal of biofilms
US9745366B2 (en) 2013-09-23 2017-08-29 University Of Southern California Compositions and methods for the prevention of microbial infections
US11248040B2 (en) 2013-09-26 2022-02-15 Trellis Bioscience, Llc Binding moieties for biofilm remediation
US10233234B2 (en) 2014-01-13 2019-03-19 Trellis Bioscience, Llc Binding moieties for biofilm remediation
AU2015227075A1 (en) * 2014-03-06 2016-09-22 Ohio State Innovation Foundation Probiotic formulations and methods for use
US10624934B2 (en) 2014-03-06 2020-04-21 Research Institute At Nationwide Children's Hospital Prebiotic formulations
WO2016154491A1 (en) * 2015-03-25 2016-09-29 Trellis Bioscience, Llc Binding moieties for biofilm remediation
AU2016303688B2 (en) * 2015-07-31 2023-06-15 Research Institute At Nationwide Children's Hospital Peptides and antibodies for the removal of biofilms
WO2017066719A2 (en) 2015-10-14 2017-04-20 Research Institute At Nationwide Children's Hospital Hu specific interfering agents
JP7514621B2 (ja) * 2017-01-04 2024-07-11 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル Dnabiiワクチンおよび強化された活性を有する抗体
AU2018206560B9 (en) * 2017-01-04 2025-04-03 Research Institute At Nationwide Children's Hospital Antibody fragments for the treatment of biofilm-related disorders
AU2018236271B2 (en) 2017-03-15 2023-12-21 Research Institute At Nationwide Children's Hospital Composition and methods for disruption of bacterial biofilms without accompanying inflammation
JP7541513B2 (ja) * 2018-10-05 2024-08-28 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル 細菌バイオフィルムの酵素的破壊のための組成物および方法
SG11202103001PA (en) 2018-10-05 2021-04-29 Res Inst Nationwide Childrens Hospital Hmgb1 protein derivatives for the removal of biofilms cross-reference to related application
US12569524B2 (en) 2018-10-22 2026-03-10 Research Institute At Nationwide Children's Hospital Compositions and methods for preventing and treating antibiotic induced pathologies using probiotics in the biofilm state
WO2020247536A1 (en) 2019-06-03 2020-12-10 Research Institute At Nationwide Children's Hospital Prebiotic formulations for prevention of sepsis and necroenterocolitis induced neurodevelopmental deficiencies
WO2021007260A2 (en) 2019-07-08 2021-01-14 Research Institute At Nationwide Children's Hospital Antibody compositions for disrupting biofilms
WO2023228443A1 (ja) 2022-05-24 2023-11-30 株式会社オクト バイオフィルムを破壊するための溶液及びその製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2444541T3 (es) * 2009-06-03 2014-02-25 Algipharma As Oligómeros de alginato para usar para superar la multirresistencia a fármacos en bacterias
RU2563809C2 (ru) * 2009-09-04 2015-09-20 Мпекс Фармасьютикалс, Инк. Применение левофлоксацина в форме аэрозоля для лечения муковисцидоза
MX2012010793A (es) * 2010-03-29 2013-05-09 Univ Southern California Composiciones y metodos para la eliminacion de biopeliculas.
EP2613797B1 (en) * 2010-09-09 2015-11-04 University Of Southern California Compositions and methods for the removal of biofilms

Similar Documents

Publication Publication Date Title
JP2016521752A5 (https=)
CY1122245T1 (el) Pd-1 αντισωμα, θραυσμα δεσμευσης αντιγονου αυτου, και ιατρικη εφαρμογη αυτου
JOP20170004B1 (ar) الأجسام المضادة لببتيد بيتا النشوي مضاد N3pGlu واستخداماته
PH12019502361A1 (en) ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
JP2021504412A5 (https=)
JP2014221779A5 (https=)
CN110366560A (zh) 抗b7-h4抗体、其抗原结合片段及其医药用途
JP2015503422A5 (https=)
EA201291336A1 (ru) Замещенные 5-фтор-1н-пиразолопиридины и их применение
JP2015528502A5 (https=)
EA201890162A1 (ru) Антитела к cd40 с повышенной агонистической активностью
JP2013519675A5 (https=)
JP2019526543A5 (https=)
JP2015504870A5 (https=)
JP2015525757A5 (https=)
EP3846796A4 (en) METHODS OF TREATMENT OF CYTOKINE RELEASE SYNDROME
MA47362A (fr) Anticorps anti-tnf, compositions et méthodes pour le traitement du rhumatisme psoriasique actif
EA201490552A1 (ru) Холиновая соль замещенного циклобутендиона, обладающая противовоспалительной способностью
IL282827A (en) Bispecific cd123 x cd3 diabodies for the treatment of hematologic malignancies
JP2014513678A5 (https=)
JP2015531397A5 (https=)
JO3565B1 (ar) الأجسام المضادة لشبيه الأنجيوبوييتين– 4 وطرق استخدامها
EA201790590A1 (ru) Гуманизированное моноклональное антитело, ингибирующее ферментативную активность сосудисто-эндотелиальной липазы
EA202092085A1 (ru) ТЕРАПЕВТИЧЕСКИЕ АНТИТЕЛА ПРОТИВ sPLA2-GIB И ИХ ПРИМЕНЕНИЕ
JP2013523758A5 (https=)